Health Condition 1: C73- Malignant neoplasm of thyroid gland
Conditions
Interventions
Intervention1: INJECTION OF ICG: Concentration-25 mg vial diluted in 10 mL sterile distilled water
Dose-1 mL IV bolus x2 times
Total dose- 5mg
Observe for fluorescence with in 45-60 seconds of injec
Sponsors
Nil
Eligibility
Inclusion criteria
Inclusion criteria: Patients undergoing Elective Total / Hemi. Thyroidectomy with or without central neck dissection . Able and willing to give informed consent
Exclusion criteria
Exclusion criteria: Known allergy to ICG or iodine contrast agent Severe hepatic dysfunction Pregnant or Breast feeding women Emergency thyroid surgery where protocol cannot be followed Prior extensive neck dissection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Parathyroid detection rateTimepoint: Parathyroid glands are identified intraoperatively at 2 points before superior pedicel ligation and after specimen removal | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Correlation between fluorescence intensity & post operative PTH 2)Correlation between fluorescence intensity & post operatiive calcium 3)Incidence of temporary hypothyroidism 4)Frequency of ICG related adverse eventsTimepoint: 1)baseline, 6hours,24 hours, 48 hours & 1 month | — |
Countries
India
Contacts
Public ContactDr Juvvalapalepu satyaveni
AIIMS Mangalagiri
Outcome results
None listed